Penrhos Bio


Remora is an award-winning biotechnology company dedicated to creating sustainable biofilm prevention technology inspired by the natural biology of red seaweed. Their patented Remora® technology effectively and sustainably blocks biofilm formation across various applications including textiles, paints, coatings, and healthcare. Their mission is to see a world free from harmful biofilms, which are a significant global problem costing over $4 trillion annually. The company aims to be a leading brand in sustainable anti-biofilm solutions.

Industries

biotechnology
life-science
medical

Nr. of Employees

small (1-50)

Penrhos Bio

2 Leman Street, London, England, E1W 9US


Products

Biocompatible 3D-printable dental resins and milling blanks with embedded anti-biofilm actives

Dental-grade resins and milling blanks formulated to include anti-biofilm molecules for use in 3D-printed dental liners, guides and restorations; cleared for use in North American markets per published approvals.

3D-printed audiology devices with anti-biofilm formulation

Custom 3D-printed hearing-aid shells/materials formulated with anti-biofilm actives to reduce microbial contamination in wearable audiology devices.

Coatings and encapsulated formulations for anti-fouling and surface protection

Coating formulations and encapsulation approaches that deliver anti-biofilm actives to a range of substrates, including marine hulls, industrial surfaces and paints to mitigate fouling and biocorrosion.


Services

On-site analytical chemistry, method development, and formulation design services to support partner product development and testing.

Commercial licensing of anti-biofilm active chemistry with co-development and integration support for partners across dental, textiles, coatings, cleaning and marine sectors.

Design and execution of applied trials in industrial laundry systems, dishwashers, coatings and device use-cases to validate durability and microbial reduction in operational environments.

Expertise Areas

  • Anti-biofilm product development
  • Formulation chemistry and scale-up
  • Analytical method development and testing
  • Regulatory compliance for chemicals and medical devices
  • Show More (3)

Key Technologies

  • Lactam-based anti-biofilm molecules
  • Quorum‑communication inhibition (microbial signalling blockade)
  • 3D-printable resins and milling blank integration
  • Coatings and encapsulation for anti-fouling
  • Show More (2)

News & Updates

Remora, in partnership with Penrhos Bio, was announced as a winner in the Scotland Life Sciences Achievements Awards 2024 in the Innovative Collaboration Category, reflecting the successful partnership with Unilever and Pro3dure in developing MSI technology for preventing harmful biofilms in 3D printed dental and audiology devices.

Remora announced a licensing partnership with Beyond Surface Technologies AG, a Swiss pioneer in green-chemistry solutions for textile finishing, founded in 2008.

Remora announced a strategic licensing agreement with Star Helix, an R&D and technology-transfer company focused on next-generation materials for human spaceflight, marking a significant step in deploying its biofilm-prevention technology in outer space.

Remora's biofilm-prevention technology has been officially approved under UK REACH regulations, one of the most rigorous chemical safety frameworks in the world.

Biocompatible dental materials containing Remora's anti-biofilm technology have received full regulatory approval in the US and Canada, developed through collaboration with Penrhos Bio and Pro3dure Medical GmbH.

Pro3dure Medical GmbH launched a 3D printable polymer containing Remora® for use in dental reliners, helping control harmful biofilms. The market for 3D printed dental products is rapidly growing.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.